A complete range of Tablets is available with us and we can provide the demanded product by our domestic as well our international customers also.
Rudipin T is a trusted brand of Telmisartan and Amlodipine Tablets IP, designed to provide effective, dual-action control of hypertension (high blood pressure). This combination medication ensures comprehensive cardiovascular protection by targeting both blood vessel relaxation and resistance reduction.
Manufactured under strict quality parameters, Rudipin T is aimed at efficacy, safety, and patient compliance, making it a reliable choice for long-term blood pressure management.
Dual Action Formula: Combines Telmisartan (ARB) and Amlodipine (Calcium Channel Blocker) for superior blood pressure control.
Provides 24-hour efficacy with once-daily dosing.
Helps lower the risk of heart attack, stroke, and kidney complications.
Improves patient adherence with convenient combination therapy.
Developed under quality-focused processes for reliable outcomes.
Telmisartan (40/80 mg as per formulation): Blocks angiotensin II receptors, relaxing blood vessels and reducing blood pressure.
Amlodipine (5/10 mg as per formulation): Prevents calcium from entering the walls of blood vessels, reducing vascular resistance and easing blood flow.
Together, this synergy leads to effective hypertension management, especially for patients requiring combination therapy.
Brand Name: Rudipin T
Composition: Telmisartan + Amlodipine Tablets IP
Form: Oral Tablet
Therapeutic Class: Antihypertensive (ARB + Calcium Channel Blocker)
Use: Management of high blood pressure (hypertension)
Quality Assurance: Manufactured under stringent quality guidelines to ensure efficacy and safety
Provides dual-action hypertension control in one tablet
Manufactured following strict quality and safety standards
Designed for efficacy, purity, and patient safety
A trusted choice recommended by healthcare professionals for improved blood pressure management
If left untreated, hypertension (high blood pressure) can silently harm the heart, kidneys, and blood vessels, increasing the chances of stroke and heart attack. With Rudipin T, patients benefit from combined therapy in a single tablet, ensuring effective and convenient management of blood pressure.
Glave M2 is a trusted brand formulated with Glimepiride 2 mg and Metformin 500 mg, designed to provide effective blood sugar control in patients with Type 2 Diabetes Mellitus.
This dual-action therapy helps manage blood glucose more effectively by combining the insulin-secreting action of Glimepiride with the insulin-sensitizing effect of Metformin. Glave M2 is manufactured under stringent quality standards, ensuring efficacy, safety, and patient compliance.
Dual-action blood sugar management with Glimepiride 2 mg + Metformin 500 mg.
Helps achieve better glycemic control in Type 2 Diabetes.
Reduces the risk of long-term complications like heart disease, kidney damage, and neuropathy.
Effective in controlling both fasting and post-meal (prandial) blood sugar levels.
Developed with a focus on efficacy and safety in diabetes care.
Glimepiride 2 mg: A sulfonylurea that stimulates the pancreas to release insulin, lowering blood sugar levels.
Metformin 500 mg: A biguanide that decreases liver glucose production and improves the body’s insulin sensitivity.
Together, they provide a holistic blood sugar control mechanism, ensuring effective and sustained management of Type 2 Diabetes.
Brand Name: Glave M2
Composition: Glimepiride 2 mg + Metformin 500 mg Tablets
Form: Oral Tablet
Indication: Type 2 Diabetes Mellitus management
Therapeutic Class: Oral Antidiabetic (Sulfonylurea + Biguanide)
Quality Assurance: Manufactured under strict quality guidelines to ensure high efficacy and safety
Trusted combination of Glimepiride 2 mg and Metformin 500 mg
Helps regulate both fasting and post-meal glucose
Manufactured under strict quality protocols
Supports long-term diabetes management with efficacy and safety
Uncontrolled Type 2 Diabetes can lead to severe complications such as cardiovascular disorders, kidney failure, and nerve damage. With Glave M2, patients benefit from a reliable and clinically effective treatment option, recommended by healthcare professionals for comprehensive diabetes management.
Glave M1 is a trusted oral antidiabetic formulation that combines Glimepiride 1 mg and Metformin 500 mg for the effective management of Type 2 Diabetes Mellitus. This dual-action therapy helps maintain better control of blood sugar levels while reducing the long-term risks of diabetes-related complications.
Manufactured under strict quality parameters, Glave M1 is designed to provide efficacy, safety, and patient compliance, making it a reliable choice in long-term diabetes management.
Dual-action control with Glimepiride 1 mg & Metformin 500 mg.
Helps regulate both fasting and postprandial (after meal) blood sugar levels.
Reduces the risk of complications related to heart, kidneys, nerves, and blood vessels.
Improves the body’s insulin sensitivity and utilization.
Designed for consistent efficacy and safety in diabetes care.
Glimepiride 1 mg (Sulfonylurea): Stimulates the pancreas to release more insulin, lowering blood glucose.
Metformin 500 mg (Biguanide): Reduces glucose production in the liver and enhances peripheral glucose uptake, improving insulin sensitivity.
By combining these actions, Glave M1 ensures comprehensive glycemic control, making it suitable especially for patients who need combination therapy at a lower Glimepiride strength.
Brand Name: Glave M1
Composition: Glimepiride 1 mg + Metformin 500 mg Tablets
Form: Oral Tablet
Indication: Management of Type 2 Diabetes Mellitus
Therapeutic Class: Oral Antidiabetic (Sulfonylurea + Biguanide)
Quality Assurance: Manufactured under stringent quality standards for efficacy and safety
Balanced combination of low-dose Glimepiride with Metformin
Helps achieve steady glycemic control with minimized risk of hypoglycemia
Manufactured under well-defined quality checks
Designed for efficacy, tolerability, and patient satisfaction
Uncontrolled diabetes can cause long-term damage to vital organs including the heart, kidneys, nerves, and eyes. Glave M1 offers a reliable and effective treatment option, supporting healthy and sustainable diabetes management when used under medical supervision.
© Copyright 2025 | Medimind Drugs & Chemicals. All Rights Reserved